| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.38B | 104.78B | 106.57B | 107.41B | 109.12B | 106.00B |
| Gross Profit | 29.93B | 29.27B | 30.06B | 29.58B | 26.81B | 31.04B |
| EBITDA | 8.03B | 8.35B | 8.65B | 8.60B | 6.60B | 11.97B |
| Net Income | 3.45B | 3.71B | 4.09B | 4.14B | 2.78B | 6.95B |
Balance Sheet | ||||||
| Total Assets | 58.01B | 59.49B | 57.77B | 55.36B | 53.34B | 53.81B |
| Cash, Cash Equivalents and Short-Term Investments | 3.53B | 5.49B | 4.76B | 3.81B | 2.23B | 5.91B |
| Total Debt | 18.83B | 20.29B | 19.88B | 19.65B | 19.07B | 16.47B |
| Total Liabilities | 41.62B | 43.33B | 43.10B | 41.92B | 42.10B | 40.98B |
| Stockholders Equity | 16.39B | 16.16B | 14.67B | 13.43B | 11.23B | 12.83B |
Cash Flow | ||||||
| Free Cash Flow | 3.13B | 2.83B | 4.48B | 3.81B | -1.51B | 5.08B |
| Operating Cash Flow | 7.00B | 6.56B | 7.37B | 8.62B | 4.02B | 8.63B |
| Investing Cash Flow | -3.90B | -3.65B | -2.86B | -4.76B | -5.50B | -3.15B |
| Financing Cash Flow | -2.46B | -2.19B | -3.55B | -2.29B | -2.20B | -8.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $59.38B | 17.20 | 21.74% | 4.79% | 0.47% | -16.65% | |
73 Outperform | $421.95B | 47.79 | 28.27% | 0.59% | 9.23% | 12.69% | |
68 Neutral | $21.46B | 17.08 | 35.90% | ― | -19.68% | ― | |
67 Neutral | $932.53B | 40.50 | 24.26% | 0.85% | 5.87% | 21.68% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $25.03B | 15.99 | 18.65% | 1.88% | 4.72% | 35.43% | |
61 Neutral | $10.88B | 19.19 | 26.59% | ― | 5.92% | 0.80% |